Follow-The-Filings

Security

Atea Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 exit max 0.0% (Renaissance Technologies LLC)

owners 8
max % 0.0%
tracked value $29M
qoq A 3 R 4 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 1,166,400 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 4,227,110 $15M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 745,415 $3M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 379,314 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 349,932 $2M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 119,553 $643 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 48,401 $260 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 46,109 $248 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 113,585 $405 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$135.96M -$168.38M -$158.35M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $590.46M $462.36M $310.99M
Total non-current assets * $4.51M $2.31M $4.23M
Total assets $594.97M $464.67M $315.22M
Total current liabilities $32.38M $18.6M $39.78M
Total non-current liabilities * $7.4M $7.2M $0.00
Total equity $555.19M $438.87M $275.43M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$85.4M -$135.5M -$132.03M
Cash from investing $40.3M $56.1M $188.79M
Cash from financing $257,000 $267,000 -$25.74M
Net change in cash -$44.84M -$79.13M $31.02M

ownership over time

filing count by report period · click a bar for that quarter’s holders